Jacques Dumas, Chief Scientific Officer at TETRAPHASE PHARMACEUTICALS INC (TTPH), sold 7,167 shares at $6.21 ($45K) on 2018-01-09, disclosed to the SEC on 2018-01-11.
Scheduled sale ($45k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| TTPH | SELL | 2017-11-02 | $106K | — | Filing → |
| TTPH | SELL | 2017-08-24 | $105K | — | Filing → |
| TTPH | SELL | 2017-08-21 | $42K | — | Filing → |